WHAT IS THE IMPACT OF ADDING EXTRA HEALTH DIMENSIONS TO THE EQ-5D?

Published Apr 15, 2015
Oxford, UK  -  Generic preference-based measures of health are commonly used to evaluate the impact of diseases and their treatments on overall health related quality of life by weighting their dimensions using people’s value judgements. However, these measures, including the EQ-5D, may miss key dimensions of health for some conditions. A team of researchers from Oxford University, Brunel University, and Sheffield University explored the potential solution of adding extra dimensions to the EQ-5D, a practice known as a ‘bolt-on’ approach. They developed three dimensions describing hearing impairment, vision impairment, and tiredness to add separately to the five core dimensions of the EQ-5D. Interviews were undertaken among 300 members of the UK general public to elicit people’s preferences for the health states with and without the extra dimensions, and data were analysed to examine the magnitude and direction of impact on health state values of the extra dimensions. Study co-author, Dr. Yaling Yang, PhD, from the University of Oxford concluded, “Each of the bolt-on dimensions had a significant impact on values for EQ-5D health states. The extent and direction of the impact of the bolt-on varied according to the level of severity of the bolt-on dimension and the severity of the state to which it was added. The results of this research suggest that simple valuation of these bolt-on items may not be possible; however, further research is required to confirm this exploratory finding.” The full study, “An Exploratory Study to Test the Impact on Three “Bolt-On” Items to the EQ-5D,” is available Open Access in Value in Health.

Related Stories

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×